However, our results clearly demonstrate that augmented NFE2L1 expression grants invasion activity to immortalized liver cells (Ch-L) and non-aggressive hepatoma cells (SNU387), suggesting a differential role of NFE2L1 according to cellular context. This evidence concerns the gene NFE2L1 and hepatocellular carcinoma.